Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
April 30, 2024
LDT Final Rule: Shifting the LDT Battlefield
April 25, 2024
FDA Updates Draft Guidance on Promotional Labeling and Advertising Considerations for Biological Reference Products and Biosimilars
February 20, 2024
FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials
March 6, 2024
Ursula Henninger Inducted Into American College of Trial Lawyers
April 18, 2024
King & Spalding Secures Defense Jury Verdict for Johnson & Johnson in Cosmetic Talcum Powder Litigation